AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Budgeting mistakes can derail your financial goals. Learn what not to do in budgeting and set yourself up for financial success.
26,044 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A fresh recall of magsafe battery chargers recalled details new fire hazards linked to lithium-ion cells, with refund...
Google Gemini AI projects a sharp, liquidity-driven Bitcoin rally to as high as $150,000 by the end of 2026, undersco...
Oil price moves can lift bank profits in certain scenarios. This article breaks down two upside reasons higher prices...
JPMorgan Chase delivered a record quarterly performance, yet Jamie Dimon cautioned that the current market sprint cou...
Oracle’s stock has fallen from its AI-redemption peak as management bets heavily on data-center compute. Analysts are...
Philanthropy headlines are buzzing as Warren Buffett shifts a long-standing gift pattern. This piece breaks down what...
As AI surges, regulators move faster than hype. Markets put odds of model access curbs at about 27.5% for 2026, reviv...
A free game download turned into a doorway for hackers to access crypto wallets and steal hundreds of thousands. This...
A closer look at Janus Henderson's CLO ETFs shows a safety-first anchor in JAAA and a bolder, higher-yield challenger...
A cheaper Brazil-focused ETF is outperforming its larger peer in 2026, prompting a rethink of how investors access Br...
New labor data reveals a troubling disconnect: participation falls while unemployment headlines stay resilient. Inves...